Pre-Clinical Cell-Based Therapy for Limbal Stem Cell Deficiency.

J Funct Biomater · 2015 · PMC4598682 · PMID 26343740

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a strong trendno p-value reported

There is currently a strong trend toward applying autologous sources as there is no risk for immunological reactions and, therefore, no requirement for immunosuppressive therapy with all known side effects [ 28 ].

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.